Pain Elimination and Anxiety Control Through Experiential Virtual Reality

Launched by CHILDREN'S HOSPITAL LOS ANGELES · Jul 11, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how different types of virtual reality can help reduce pain and anxiety in children and young adults aged 8 to 21 who need to have an intravenous (IV) line placed in the emergency department. The study compares three groups: one group will use an active virtual reality experience where they can interact and engage, another group will use a passive virtual reality experience that is more like watching a movie, and the third group will receive standard care, which is the usual method of distraction during the procedure. Researchers want to see if the active virtual reality experience is better at lowering pain and anxiety levels than the other two methods.

To be eligible for this trial, participants should be between 8 and 21 years old and need to undergo IV placement. They should be able to understand and follow study instructions, and their caregivers must speak either English or Spanish. However, participants with certain conditions, such as significant psychiatric issues or those who have taken certain medications shortly before the procedure, may not be eligible. If you or someone you know fits the age range and is interested in participating, this study could provide an opportunity to help improve the experience of a common medical procedure.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Children and adolescents 8-21 years old undergoing IV placement .
• • Ability to understand study procedures and to comply with them for the entire length of the study.
• • Participants and caregiver speaking English or Spanish.
• Exclusion Criteria:
• • Participants with psychiatric, developmental delay, visual or auditory deficits that would interfere with virtual reality gameplay (decision based on treating clinicians' evaluation).
• • Participants receiving narcotics, opioids, or anxiolytics 8 hours prior (Tylenol and ibuprofen do not count).
• • Participants with pain so significant that consent/assent is not possible (decision based on treating clinician evaluation).
• • Critically ill Participants (ESI 1).